Showing results (1-10 of 86) with videos related to
Sort By:
Pageof 9
Cancers|September 12, 2020
The Landscape of CAR-T Cell Clinical Trials against Solid Tumors-A Comprehensive OverviewNiels SchaftInternational Journal of Molecular Sciences|November 27, 2025
Special Issue "Molecular Advances in Cancer Immunotherapy"Niels SchaftMethods in Molecular Biology (Clifton, N.J.)|December 20, 2024
The Role of Non-coding RNAs in Tumorigenesis, Diagnosis/Prognosis, and Therapeutic Strategies for Cutaneous MelanomaNiels Schaft, Jan DörrieHuman Gene Therapy|January 12, 2018
Chimeric Antigen Receptors in Different Cell Types: New Vehicles Join the RaceDennis C Harrer, Jan Dörrie, Niels SchaftInternational Journal of Molecular Sciences|May 21, 2020
CARs: Beyond T Cells and T Cell-Derived Signaling DomainsNico M Sievers, Jan Dörrie, Niels SchaftInternational Journal of Molecular Sciences|November 30, 2019
CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities-Merits and ChallengesDennis C Harrer, Jan Dörrie, Niels SchaftInternational Journal of Molecular Sciences|February 11, 2023
CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell TherapyDennis Christoph Harrer, Jan Dörrie, Niels SchaftInternational Journal of Molecular Sciences|August 27, 2021
T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic OptionsLaura Gehrcken, Tatjana Sauerer, Niels Schaft, et al.Experimental Dermatology|June 2, 2016
Combining a chimeric antigen receptor and a conventional T-cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi-hit immunotherapy of melanomaUgur Uslu, Gerold Schuler, Jan Dörrie, et al.Genes|September 28, 2024
The Role of the Large T Antigen in the Molecular Pathogenesis of Merkel Cell CarcinomaJulia Myrda, Franziska Bremm, Niels Schaft, et al.Pageof 9